In early 2021, the FDA approved the first long-acting injectable antiretroviral, cabotegravir/rilpivirine (LA-CAB/RPV), for people with HIV who are doing well on their current treatment. A high body mass index (BMI)—30 kg/m² or more—is known to increase the risk of treatment failure, but there's not
In Europe, HIV is still a big problem among women, and many chances to test for it are missed. Family Planning Centers (FPCs) should offer HIV testing, but they often don't. A small study in France checked if it's possible and acceptable for FPC staff who aren't doctors to offer quick HIV tests to v
In Porto Alegre, Brazil, early diagnosis of opportunistic infections (OIs) can dramatically improve the lives of people living with HIV/AIDS (PLWHA). A recent study explored the feasibility of using rapid tests to diagnose tuberculosis, histoplasmosis, and cryptococcosis in advanced HIV/AIDS patient
Imagine you're waiting for a new liver or kidney, and you have HIV. Soon, your wait might get a bit shorter thanks to a new rule from the U. S. Department of Health and Human Services. This rule, announced recently, means that people living with HIV can receive organs from HIV-positive donors. This
People living with HIV who need a new kidney or liver have a new chance. The U. S. health officials just said that soon, they can get organs from donors who also have HIV. Before, this was only allowed in special research studies. Now, the change aims to help everyone waiting for an organ, both with
Great news! The world is seeing fewer new HIV infections and deaths. This is a big win, especially in sub-Saharan Africa, where numbers have dropped the most. But, there's still work to do. Some places, like Eastern Europe and the Middle East, are seeing more new cases. We're far from the 2030 targe
You might have heard about mobile apps helping people with HIV manage their medication. But are these apps following the rules? A recent study dug into this, checking if these apps are telling us what they're supposed to. These apps are designed to help people with HIV stick to their antiretroviral
HIV/AIDS remains a significant health concern in Colombia. To understand its impact, let's look at how different departments have been affected from 2018 to 2022. Instead of just numbers, let's consider what these stats mean for the people and communities involved. Imagine different cities, each fa
Young people with HIV often struggle to stick to their medication routine. While face-to-face counseling is the norm, it doesn't always work well. Researchers in Uganda wondered if mobile health tools, like interactive voice response (IVR) calls, could help. They ran a trial to see if these calls co
Long-acting PrEP, which stands for pre-exposure prophylaxis, is shaking up the fight against HIV in areas with high infection rates. Research shows it's safe and effective, giving it the potential to revolutionize prevention methods. Let's take a look at how people are responding to these new option
